Relmada Therapeutics Asset Turnover Growth & History (RLMD)
Relmada Therapeutics's asset turnover was 0.00 for fiscal 2025.
View full Relmada Therapeutics company overviewRelmada Therapeutics annual asset turnover history
| Fiscal year | Period ended | Asset turnover | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.00 | 0.00 | — |
| 2024 | 2024-12-31 | 0.00 | 0.00 | — |
| 2023 | 2023-12-31 | 0.00 | 0.00 | — |
| 2022 | 2022-12-31 | 0.00 | — | — |
| 2013 · Aug 31 | 2013-08-31 | 0.27 | — | — |
Relmada Therapeutics quarterly asset turnover
| Fiscal quarter | Period ended | Asset turnover | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.00 | — | — |
| Q1 2026 | 2026-03-31 | 0.00 | — | — |
| Q1 2014 · Feb 28 | 2014-02-28 | 0.43 | — | — |
| Q1 2014 · Nov 30 | 2013-11-30 | 0.32 | — | — |
Relmada Therapeutics asset turnover trends
Between the periods ended 2013-08-31 and 2025-12-31, Relmada Therapeutics's asset turnover decreased from 0.27 to 0.00, a change of −0.27. The latest reported quarter, Q2 2026, shows 0.00.
What asset turnover means
Asset turnover measures how much revenue a company generates for each unit of assets employed in the business. A higher ratio generally indicates more efficient asset use, although useful comparisons depend heavily on the industry.
How asset turnover is calculated
TickerStat calculates annual asset turnover as reported revenue divided by average total assets. Quarterly values use trailing-12-month revenue and average assets over the corresponding one-year period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Relmada Therapeutics source filings ↗